BMC Biology is calling for submissions to our Collection on Cancer metabolism. Cancer metabolism is a developing field that explores the biochemical and physiological changes that occur in cancer cells, which often exhibit distinct metabolic pathways compared to normal cells. Alterations such as the Warburg effect, where cancer cells preferentially utilize glycolysis for energy production even in the presence of oxygen, play a pivotal role in tumor progression and survival. Understanding the intricacies of cancer metabolism provides insights into how tumors adapt to their microenvironments and highlights potential therapeutic targets for intervention.

Future research in cancer metabolism promises to yield transformative insights that could reshape therapeutic approaches and improve precision medicine. The continued focus on metabolic pathways may lead to the identification of new biomarkers for cancer diagnosis and prognosis, as well as novel strategies to enhance the sensitivity of cancer cells to treatment. As we deepen our understanding of the metabolic landscape of tumors, we may uncover innovative strategies that exploit these vulnerabilities, ultimately leading to novel and more effective cancer treatments, as well as improved patient outcomes.

Recent advancements in the field, including the identification of metabolic reprogramming strategies and the influence of diet on tumor growth, have opened new avenues for research. Investigations into the roles of lipids, fatty acids, and dietary interventions, such as ketogenic diets, are revealing potential methods for manipulating tumor metabolism and enhancing the efficacy of existing treatments. We invite researchers to submit their work to this Collection, which aims to showcase groundbreaking research and technologies addressing cancer metabolism and support the advancement of this field, encompassing a wide array of topics related to metabolic pathways and their implications for cancer biology and therapy.

Potential topics include but are not limited to:

• Metabolic reprogramming in cancer cells
• The Warburg effect and its implications
• Role of mitochondria in cancer metabolism
• Impact of dietary interventions on tumor metabolism
• Glycolysis and lipid metabolism in cancer
• Animal models
• Imaging and method developments
• Metabolic engineering

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Biology is calling for submissions to our Collection on Human genomic diversity..

Human genomic diversity encompasses the vast genetic and genomic variation found within and among populations across the globe. This Collection seeks to explore the intricate tapestry of human genetic and genomic diversity, highlighting the need for comprehensive characterization of world populations, historical migration patterns, adaptations to diverse environments, and the resulting population structures that characterize different ethnic groups, including underrepresented populations. By integrating insights from population genomics, evolutionary biology, and anthropology, we aim to deepen our understanding of how genomic variation shapes human health and disease susceptibility.

The study of human genomic diversity is crucial for advancing personalized medicine and improving healthcare outcomes. Recent advances in genomic technologies, such as high-throughput sequencing and improved data representation techniques, have enabled researchers to explore the complexities of genetic diversity in unprecedented detail. These advances pave the way for identifying the full complement of genetic factors that influence disease susceptibility and treatment responses across different populations. As we uncover the genetic and genomic basis of health disparities, more equitable approaches to genomic medicine can be developed.

Looking to the future, continued research in human genomic diversity may lead to groundbreaking discoveries that enhance our understanding of human evolution and adaptation. As we further investigate the genetic underpinnings of diseases and their interactions with environmental factors, we may also develop targeted therapies that are more effective for diverse populations, ultimately leading to improved health outcomes for all.

Topics of interest include, but are not limited to:

• Human population history and migration
• Adaptation to environment and population structure
• Ethnic diversity in genomics and disease susceptibility
• Equity and inclusion in genomic medicine
• Phylogenomics and evolutionary genomics
• Genomic technologies
• Computational genomics

This Collection supports and amplifies research related to SDG 3 (Good Health and Well-being).

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.